Assetmark Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 16.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 4,145,742 shares of the biopharmaceutical company’s stock after selling 838,495 shares during the quarter. Assetmark Inc. owned approximately 0.07% of Pfizer worth […]